Crum Brian T
Insider CIK 1792747 · LXRX VP, General Counsel & Secr.
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-02-28 | 2026-03-03 | 33,457 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-02-28 | 2026-03-03 | 69,386 | — | $0 | 69,387 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-02-28 | 2026-03-03 | 170,163 | — | $0 | 340,327 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-02-28 | 2026-03-03 | 69,386 | — | $0 | 330,201 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2026-02-28 | 2026-03-03 | 105,019 | $1.47 | $154.4K | 428,802 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-02-28 | 2026-03-03 | 33,457 | — | $0 | 363,658 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-02-28 | 2026-03-03 | 170,163 | — | $0 | 533,821 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-02-12 | 2026-02-17 | 299,710 | — | $0 | 299,710 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-02-12 | 2026-02-17 | 449,560 | — | $0 | 449,560 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 69,387 | — | $0 | 138,773 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 33,456 | — | $0 | 33,457 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 26,097 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2025-02-28 | 2025-03-03 | 45,622 | $0.67 | $30.6K | 260,815 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 69,387 | — | $0 | 306,437 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 33,456 | — | $0 | 237,050 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 26,097 | — | $0 | 203,594 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 765,730 | — | $0 | 765,730 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 510,490 | — | $0 | 510,490 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 33,457 | — | $0 | 66,913 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 26,096 | — | $0 | 26,097 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 8,750 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 8,750 | — | $0 | 143,548 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 26,096 | — | $0 | 169,644 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 33,457 | — | $0 | 203,101 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2024-02-28 | 2024-02-29 | 25,604 | $2.62 | $67.1K | 177,497 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 208,160 | — | $0 | 208,160 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 208,160 | — | $0 | 208,160 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 26,097 | — | $0 | 52,193 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 8,750 | — | $0 | 8,750 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 21,030 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2023-02-28 | 2023-03-01 | 20,537 | $2.17 | $44.6K | 134,798 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 26,097 | — | $0 | 155,335 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 8,750 | — | $0 | 129,238 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 21,030 | — | $0 | 120,488 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 301,100 | — | $0 | 301,100 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 100,370 | — | $0 | 100,370 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 8,750 | — | $0 | 17,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 11,100 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 21,030 | — | $0 | 21,030 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 8,750 | — | $0 | 114,517 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 11,100 | — | $0 | 84,737 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 21,030 | — | $0 | 105,767 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2022-02-28 | 2022-02-28 | 15,059 | $2.85 | $42.9K | 99,458 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 234,870 | — | $0 | 234,870 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 78,290 | — | $0 | 78,290 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 11,100 | — | $0 | 11,100 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 1,517 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 21,030 | — | $0 | 42,060 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-02-28 | 2021-03-02 | 5,118 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2021-02-28 | 2021-03-02 | 14,860 | $7.19 | $106.8K | 73,637 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 1,517 | — | $0 | 51,249 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 5,118 | — | $0 | 56,367 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 11,100 | — | $0 | 67,467 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-02-28 | 2021-03-02 | 21,030 | — | $0 | 88,497 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 78,760 | — | $0 | 78,760 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 26,250 | — | $0 | 26,250 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-04-22 | 2020-04-24 | 6,398 | $1.96 | $12.5K | 49,732 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2020-04-22 | 2020-04-24 | 19,893 | — | $0 | 56,130 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 2,515 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 1,518 | — | $0 | 1,517 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 5,119 | — | $0 | 5,118 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 11,100 | — | $0 | 22,200 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 1,518 | — | $0 | 26,958 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-02-28 | 2020-03-03 | 6,940 | $2.77 | $19.2K | 36,237 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 11,100 | — | $0 | 43,177 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 5,119 | — | $0 | 32,077 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 2,515 | — | $0 | 25,440 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 189,260 | — | $0 | 189,260 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 63,090 | — | $0 | 63,090 | SEC↗ |